£109.49

Prescription Drugs: Development, Pricing and Abuse (Health Care in Transition)

Health Issues

Price data last checked 100 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£109 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 1 days • 1 data points (No recent data available)

Historical

Generating forecast...

Not enough data points to display chart (need at least 2 points)

Price Distribution

Price distribution over 1 days • 1 price levels

Days at Price

Price Analysis

Most common price: £109 (1 days, 100.0%)

Price range: £109 - £109

Price levels: 1 different prices over 1 days

Description

The Food and Drug Administration (FDA) awards priority review vouchers (PRV) to drug sponsors that develop drugs for tropical diseases or rare pediatric diseases or to use as medical countermeasures. The PRV-which can be sold to another drug sponsor-may be redeemed later to receive priority review from FDA with a targeted review time of 6 months, rather than the 10-month standard review, for a drug application of the PRV holder's choice. Chapter 1 examined the number of PRVs awarded and redeemed and the drugs for which they were awarded or redeemed, and what is known about the extent to which the PRVs provide incentives for developing drugs to meet unmet needs. Chapter 2 examines the prevalence of obesity in the United States, and what is known about the use and health insurance coverage of obesity drugs. Chapter 3 discusses how to get medical care and prescription drugs during a disaster or when an emergency has been declared. The 340B Drug Pricing Program was created in 1992 to enable eligible covered entities-including certain categories of hospitals-to obtain discounts on covered outpatient drugs. Chapters 4-6 examine various aspects of this Medicare program. Chapter 7 provides an overview of how drug prices are established under Part D and describes elements of various proposals for Secretarial negotiation. To mitigate the effects of the opioid crisis in Philadelphia, a nonprofit called Safehouse announced plans to open a supervised injection site where illicit drug users could consume opioids under the supervision of trained staff, receive medical intervention in case of an overdose, and access services including addiction treatment. Chapter 8 discusses the Safehouse litigation's importance for Congress by first providing relevant factual and legal background, before identifying select considerations for Congress related to the treatment of supervised injection sites under the CSA. Parents are often concerned that their children will start (or are already) using drugs such as tobacco, alcohol, marijuana, and others-including the misuse of prescription drugs. Research supported by the National Institute on Drug Abuse (NIDA) shows the important role that parents play in preventing drug use in their children.Chapter 9 highlights parenting skills that are important in preventing the initiation and progression of drug use among youth.

Product Specifications

Format: hardcover
ASIN: 1536179701
Category: Books > Subjects > Health, Family & Lifestyle > Health Issues
Domain: Amazon UK
Release Date: 24 June 2020
Listed Since: 09 June 2020

Barcode

No barcode data available

Prescription Drugs: Development, Pricing and Abuse (Health Care in Transition)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Drugs and Drug Policy: The Control of Consciousness Alteration

The Prescription Drug Abuse Epidemic: Incidence, Treatment, Prevention, and Policy

Psychoactive Drug Abuse in Hong Kong: Life Satisfaction and Drug Use: 11 (Quality of Life in Asia, 11)

Drugs: A Healthy Understanding

Drug Policy and the Public Good

Drug Abuse: Prevention and Treatment: Volume III (The Library of Drug Abuse and Crime)

Addiction Potential of Abused Drugs and Drug Classes

The Reduction of Drug-Related Harm

Handbook of Research on the Illicit Drug Traffic: Socioeconomic and Political Consequences

PRESCRIPTION DRUGS (Substance Abuse Assassment Interventions and Treatment)

Preventing Harmful Substance Use: The Evidence Base for Policy and Practice

Drugs of Abuse: Pharmacology and Molecular Mechanisms

White Drug Cultures and Regulation in London, 1916–1960

The Encyclopedia of Drug Abuse (Facts on File Library of Health & Living)

Addictive Personalities and Why People Take Drugs: The Spike and the Moon (The United Kingdom Council for Psychotherapy Series)

Critical Approaches to Harm Reduction: Conflict, Institutionalization, (De-)Politicization, & Direct Action (Public Health in the 21st Century)

Treating Teenage Drug Abuse in a Day Care Setting

Drug Use and Abuse

Prescription Drug Diversion and Pain: History, Policy, and Treatment

Drug Control in the United States: 2014 Strategy and an Appraisal of Past Policy (Drug Transit and Distribution, Interception and Control)

Prescription Drug Abuse: Reduction Efforts & Federal Role (Alcohol and Drug Abuse)

The Cult of Pharmacology: How America Became the World’s Most Troubled Drug Culture

Drug Misuse and Community Pharmacy

Research Handbook on International Drug Policy